Tai Mei Ti A P P
Search documents
中国人工智能大会丨对话蒋俏蕾:AI离真人还差得很远,未来也未必像人
Tai Mei Ti A P P· 2025-12-03 10:05
常常会有人将AI智能与人类智能做类比,思考如今的人工智能有多像人,但在蒋俏蕾的研究中,在不 同维度的智能对比上,AI还远达不到人类智能的程度。其中最关键的差异,是AI可以模拟情感、却无 法真正拥有情感,至少在目前是。 那些人类的脆弱之处,恐惧、欲望、痛苦,恰恰是AI无法取代的地方,因为AI不会像人类一样面临生 老病死。人正是因为生命有限,才会珍惜时光,孕育出勇气、牺牲、同情和无条件的爱。这种复杂的情 感,也许AI可以从字面上读懂,但无法发自内心理解。 文 | 新浪Insights "现在的人工智能离真人还差得很远,并没有像电视剧《西部世界》里那般。现在人工智能处在工具以 上、伙伴未满的状态。" 在2025中国人工智能大会暨全国人工智能学院院长(系主任)年会上,清华大学新闻与传播学院长聘教 授、博士生导师蒋俏蕾表达了她对于人机关系的思考。 蒋俏蕾认为,也许未来具身智能机器人的身体能够做到和人的生理结构高度类似,比如害怕时心脏会狂 跳,那时才有可能会接近人类真实的情感。 她还提出了一个更具想象力的演进——也许AI并不会以人类智能为参照物"进化",而可能会成为与人类 的思考方式、协作方式完全不同的新物种,不一定遵从 ...
瑞士医疗科技公司Testmate Health研发性传播感染家用检测试剂
Tai Mei Ti A P P· 2025-12-03 10:05
图源startupticker 钛媒体APP注:自2011年以来,瑞士连续14年全球创新指数排名第一,是全球重要的创新策 源地,也是中国首个创新战略伙伴关系国,在创新发展和科技金融领域与中国具有极佳互补 性。 由Venturelab主办的"瑞士创新100强",汇聚了最佳"瑞士制造"的初创及成长期科技创新 企业,是瑞士最具国际影响力的创新生态标杆。自2011年以来,该榜单每年在瑞士全国范围 内评选出100家最具开创性和市场前景的瑞士创新企业和25家最具独角兽潜力的瑞士成长期 企业,覆盖生命科学、工程机械、机器人、信息通信、低碳科技、食品科技等领域。 为了 全方位展示和介绍瑞士最前沿的创新科技,钛媒体APP与Venturelab的中国授权合作方以明 科技(Insight Tech)合作推出《瑞士创新100强》专题,全面展示瑞士先锋科创生态的全 景。 本文为专栏第179期,介绍的Testmate Health是2025年《瑞士创新100强》上榜企业,其 致力于研发性传播感染家用检测试剂。 瑞士医疗科技公司Testmate Health(以下简称Testmate)创立于2021年,致力于研发性传播感染家用检 测试剂。 ...
亏损中逆势收购上游设备商,恩捷股份打响隔膜产业链整合第一枪
Tai Mei Ti A P P· 2025-12-03 10:03
Core Viewpoint - Enjie Co., a leading lithium battery separator manufacturer, is making a strategic acquisition of Qingdao Zhongke Hualian New Materials Co., a wet-process separator equipment supplier, amidst industry challenges and its own financial losses [1][3]. Group 1: Financial Performance and Market Conditions - Enjie Co. reported a revenue increase of 27.85% year-on-year to 9.543 billion yuan for Q3 2025, but faced a net loss of 86 million yuan, a 119.5% decline compared to the previous year [1]. - The average price of mainstream wet-process 7μm separators fell to 0.74 yuan/square meter in the first half of 2025, a 25% year-on-year decrease, indicating intense price competition in the industry [1]. - Enjie Co.'s net profit margin was only 0.95%, significantly lower than competitors like Cangzhou Mingzhu (8.34%) and Zhongcai Technology (6.58%) [2]. Group 2: Strategic Acquisition and Industry Integration - The acquisition of Zhongke Hualian represents a vertical integration strategy, allowing Enjie Co. to combine separator manufacturing with equipment supply, enhancing operational synergy [3]. - Zhongke Hualian has established production bases with a total capacity of approximately 2 billion square meters, with additional facilities under construction that could bring total capacity to 5 billion square meters [4]. - This acquisition will enable Enjie Co. to reduce equipment procurement costs, optimize production processes, and gain significant market share in the lithium battery separator industry [5]. Group 3: Future Outlook and Market Positioning - Enjie Co. believes the industry is at a critical turning point from oversupply to supply-demand balance, with new capacity additions expected to be lower than the previous year [6][7]. - The company is experiencing a stable increase in demand and order volume, indicating a recovery in the market [7]. - Enjie Co. is also expanding its global footprint with projects in Hungary and the U.S., and is preparing for next-generation battery technologies, positioning itself to navigate the industry's downturn [7][8].
“云计算春晚”又来了!不止自研AI芯片和模型,亚马逊云科技回答了一个核心问题
Tai Mei Ti A P P· 2025-12-03 06:59
美西时间12月2日早8点,"云计算春晚"亚马逊云科技 re:Invent 2025大会迎来重磅环节,亚马逊云科技首 席执行官 Matt Garman在两个小时的高强度输出中,发布了一系列产品和服务。 自研AI芯片Trainium和Nova模型都足够引人注目,这也是行业行尤为关注的两个极端,上至模型,下至 芯片,模型天梯榜上你方唱罢我登场,AI芯片前有英伟达后有谷歌TPU等,然而行业往往容易忽略一个 关键的事实: 仅靠模型和芯片无法跑通大模型商业化的正循环,真正让大模型的价值落地,需要在硬件与软件的每一 层进行优化,芯片和模型是其中的重要组成,但不是全部。 Matt Garman表示,每天驱动我们的,是让所有人都拥有自由创新的能力。这从亚马逊云科技诞生的第 一天起就是我们的使命。我们希望让宿舍里的学生、车库里的发明者,都能够访问所需的技术、基础设 施和能力,从而构建他们所想象的一切。 在20年前,这几乎是不可能的。开发者无法在不投入大量时间和资金的情况下获得所需的服务器或算 力,而那时他们花了太多时间在采购服务器、管理基础设施上,却没能真正用在构建创新上。 "为什么开发者不能专注于构建,而不是花时间在基础设施上 ...
销量狂欢的B面:车企忙着发战报,经销商忙着去库存
Tai Mei Ti A P P· 2025-12-03 06:33
2025年11月,中国汽车市场上演了一出"冰与火之歌"。 一面是可喜可贺的新能源战报:岚图实现"十连涨"破两万,零跑稳居新势力榜首破七万,小米连续三月 站稳四万大关,纪录被不断刷新。 一面却是如履薄冰的渠道预警:中国汽车流通协会数据显示,11月 库存预警指数攀升至55.6%,同比、环比双双走高,持续位于荣枯线之上。 这两组截然相反的数据,勾勒出当前车市最深刻的矛盾:车企端的"销量新高",究竟是真实需求的爆 发,还是向渠道转移的压力? 有的提前庆功,有的仍在苦战 临近年终,各车企的年度销量目标完成情况,成为衡量其战略执行与市场适应能力的首要标尺。11月的 销量数据清晰地呈现出一条分水岭:部分企业已提前撞线,而另一部分则仍在奋力冲刺,市场节奏出现 明显分化。 在本轮冲刺中,零跑汽车无疑是最大赢家。11月15日,零跑便宣布全年销量已突破50万台。这一速度不 仅远超行业预期,也为其在产品迭代、渠道扩张和战略调整上赢得了宝贵的窗口期。 小鹏汽车同样表现抢眼。年初何小鹏曾上调2025年销量目标,计划比2024年翻倍以上,也就是超过38万 辆。而今年1-11月,小鹏已累计交付39.2万台,同比大涨156%,提前达标已成定局 ...
比华为多个屏幕但更厚重,三星要用三折叠跟苹果硬碰硬
Tai Mei Ti A P P· 2025-12-03 03:27
在经历了短暂的回升之后,手机市场又迎来了下跌的风险,尤其是中国市场,已经连续两个季度负增 长。不过,从细分产品段来看,折叠屏手机仍处于一个增长的通道,不仅如此,就连苹果也多次传出明 年将会推出折叠屏的消息。 当下,折叠屏的形态主要以左右大折、上下小折为主,华为在去年推出了三折叠,一时间惊艳四座。而 在昨天,三星也紧随其后,推出了旗下首款三折叠手机——Galaxy Z TriFold,最薄处3.9mm,重量为 309g,起售价在1.7万元人民币左右。 对比华为三折叠,三星Galaxy Z TriFold在折叠方式上有所差异,采用"G"形态折叠,要多一块屏幕,但 更厚更重。作为一款比华为推出要晚上一年的产品,三星的选择虽有创新和差异,但体验上目前还说不 好孰优孰劣。身为曾经的手机创业者,罗永浩则是直接吐槽称,"这么折叠不就相当于是四块手机屏 吗?除了比华为那种方案更厚,意义在哪里呢?" 更厚更重的三折叠,可承受20万次折叠 2019年起,在三星、华为等多品牌的推动下,折叠屏开始进入到大众的视野,并成为一些品牌在高端突 围的利器。从目前全球市场的份额来看,三星和华为是折叠屏市场的领头羊,2024年,二者一共占据了 ...
AI芯片大战升级!亚马逊推出首款3nmAI芯片Trainium 3,挑战英伟达、谷歌
Tai Mei Ti A P P· 2025-12-03 02:12
Core Insights - The competition in the AI chip sector is intensifying, with Amazon launching its new AI chip Trainium 3, which is designed for high-performance generative AI workloads [2][3] - Trainium 3 is built on a 3nm process and manufactured by TSMC, offering significant improvements over its predecessor, Trainium 2 [2] - AWS emphasizes the cost-effectiveness of Trainium chips, claiming they can reduce training and inference costs by 50% compared to equivalent GPU systems [5] Group 1: Product Features and Performance - Trainium 3 boasts a computing power that is 4.4 times greater than the previous generation, with a memory bandwidth that is four times higher and a 40% increase in energy efficiency [3] - The new Trainium 3 UltraServer can deploy up to one million Trainium 3 chips, increasing the deployment capacity tenfold [3] - Each Trainium 3 chip integrates 144GB of high-bandwidth memory, while competitors like Google's TPU and NVIDIA's latest offerings have higher memory capacities [3][4] Group 2: Market Position and Competition - AWS has not provided direct performance comparisons between Trainium 3 and competitors like NVIDIA and Google, which raises questions about its competitive standing [3][6] - NVIDIA maintains a strong market position, with its CFO asserting that no competitors can challenge its dominance, citing the company's ecosystem and standards [6] - Despite competition, AWS and NVIDIA announced a collaboration to integrate NVIDIA's NVLink Fusion technology into future Trainium chips, enhancing interconnectivity and server communication [8] Group 3: Market Adoption and Future Prospects - Trainium 3's initial customer base is limited, primarily serving companies like Anthropic, which has a close relationship with AWS [10] - AWS aims to replicate the architecture developed for Anthropic on new servers to attract larger clients, although Anthropic has multiple chip options, including NVIDIA's products [10] - AWS's broader strategy includes launching various AI models and services, indicating a commitment to vertical integration in the AI space [11][12]
埃森哲成了OpenAI的“布道者”,中国的“华与华”们却在卖营销方案 | 马上评
Tai Mei Ti A P P· 2025-12-03 01:11
图片由AI生成 根据协议,埃森哲将为其数万名IT专业人员配备ChatGPT Enterprise,并成为OpenAI的首要合作伙伴, 帮助全球企业采用和部署生成式AI技术。这不仅是一次简单的商业合作,更可能成为欧美企业AI转型 从概念验证走向规模化应用的分水岭。 我们可以看到,这次合作的内容其实远不止于两家公司之间的技术授权。它实际上意图去解决众多企业 在AI时代转型效率提升、如何将AI技术有效地嵌入到企业工作流程中等关键问题,而埃森哲将会替代 OpenAI扮演这样的角色。 2025年12月1日,OpenAI与埃森哲宣布达成一项战略合作伙伴关系,这一消息可能标志着欧美企业AI转 型新纪元的到来。 其实在中文世界,这条新闻内容只有短短几句话,但详细看原版英文新闻,我们会发现该战略合作可能 蕴含着丰富的信息。 AI转型不仅涉及技术变革,更涉及工作方式和思维方式的根本改变,许多员工还会担心AI会取代自己 的工作,进而会演变成对AI转型推进的抵制。 可以预期的是,OpenAI与埃森哲的这次战略合作,会促使欧美企业AI转型速度将在未来2-3年内明显加 快。 从两家企业合作方案的细节上,我们能看到,他们正在试图构建一个成 ...
茂业商业五连板巨震:游资击鼓传花,大股东峰顶减持,谁是最后一棒?
Tai Mei Ti A P P· 2025-12-02 13:56
Core Viewpoint - The recent surge in the stock price of Maoye Commercial (600828.SH) has been accompanied by significant insider selling, raising concerns about valuation risks and the sustainability of its financial performance [2][8]. Stock Performance and Trading Activity - Maoye Commercial's stock price increased over 40% in five consecutive days, reaching a new high before the announcement of a share reduction by its controlling shareholder [2]. - On December 1, a large sell-off occurred with 224,300 shares being dumped, leading to a price drop of 3.41% after hitting a five-day limit-up [3]. - The trading volume on December 1 reached a historical high of 1.358 billion yuan, with a turnover rate of 90%, indicating extreme volatility and a rapid change in ownership of shares [5][7]. Shareholder Actions - The controlling shareholder's action involved reducing holdings by 25.1135 million shares, amounting to approximately 161 million yuan, which represents 1.45% of the total share capital [7]. - The average selling price was around 6.40 yuan per share, and the shareholding of Maoye International decreased from 86.45% to 85% post-reduction [7]. Financial Performance and Valuation - Maoye Commercial reported a 73% decline in net profit for the first three quarters, with a dynamic P/E ratio soaring to 304.46, significantly above the industry average of 49.33 [8]. - Revenue for 2024 is projected at 6.52 billion yuan, reflecting a 5.3% year-on-year decline, while net profit is expected to drop by 26.63% [8]. - The company has a high debt burden, with interest expenses reaching 211 million yuan in the first three quarters and an asset-liability ratio of 58% [10]. Operational Challenges - Despite investing over 200 million yuan in digital transformation, online business revenue remains below 5%, indicating limited success in this area [10]. - The company’s cash flow situation is precarious, with a cash balance of 207 million yuan and an average monthly cash outflow of 352 million yuan, leading to a significant operational funding gap [11].
9折“卖子”,金种子酒“弃药从酒”落地,主业突围仍艰难
Tai Mei Ti A P P· 2025-12-02 13:03
(图片系AI生成) 2025年8月28日,该股权以评估价1.4亿元首次挂牌,却因未征集到合格受让方面流标。随后公司降价 10%,于近期以1.26亿元底价由珺澄药业摘牌。 根据公告,受让方珺澄药业成立于2025年10月14日,注册地址位于深圳市福田区,控股股东为深圳三顺 制药有限公司,经营范围涵盖中草药收购、健康咨询服务等,与金种子酒无产权、业务及债权债务关 联,本次交易不构成关联交易。 出售过程略有波折,但可以看出金种子酒"卖子"的急切和决心。值得注意的是,金太阳药业并非"劣质 资产",公司成立于2000年,注册资本3000万元,实行独立自主经营、自负盈亏模式。 2024年,金太阳药业经审计营收1.61亿元、净利润618.69万元;2025年前9月营收1.03亿元,净利润仍保 持盈利57.33万元。截至2025年9月末,公司净资产1.30亿元,对应92%股权账面值约1.20亿元,1.26亿元 成交价仅溢价5%,基本属于"平价出货"。 聚焦主业仍陷多重困境 剥离医药业务的背后,是金种子酒长期亏损与现金流紧张的严峻现实。 12月1日,金种子酒(600199.SH)公告,旗下安徽金太阳生化药业有限公司已完成工商变更 ...